|

SANOFI-ADR (SNY)

US80105N1054 - ADR

46.75  +0.15 (+0.32%)

After market: 46.75 0 (0%)

News Image
11 hours ago - The Motley Fool

2 Biotech Stocks You Can Buy and Hold for the Next Decade

These stocks aren't popular on the market right now, but investors shouldn't let that scare them off.

News Image
3 days ago - Investor's Business Daily

Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales

Regeneron and Sanofi are partnered on Dupixent, a treatment for conditions tied to type 2 inflammation.

News Image
4 days ago - Seeking Alpha

Sanofi reports positive Phase 3 data on Dupixent for COPD (NASDAQ:SNY)

Sanofi's Phase 3 trial of Dupixent for COPD shows significant reduction in exacerbations, potentially making it the first approved biologic for the...

News Image
10 days ago - Chartmill

Is NASDAQ:SNY a Good Fit for Dividend Investing?

Is SANOFI-ADR (NASDAQ:SNY) a Good Fit for Dividend Investing?

News Image
15 days ago - Seeking Alpha

Sanofi stock ticks higher amid report about spinoff of consumer health business

Sanofi's ADR's rose 0.5% as reports suggest the company is considering separating its consumer health business, working with Rothschild & Co.

News Image
16 days ago - Chartmill

Don't overlook NASDAQ:SNY—it's a hidden gem with strong fundamentals and an attractive price tag.

SANOFI-ADR (NASDAQ:SNY) is an undervalued gem with solid fundamentals.

News Image
24 days ago - Investor's Business Daily

Celldex Makes A Bullish Move As It Looks To Take On Regeneron, Sanofi

The company is looking to take on Regeneron and Sanofi's Dupixent in skin diseases.

News Image
a month ago - The Motley Fool

This Stock Just Dropped By 15%: Is It a Buy?

Now could be a great opportunity to buy low.

News Image
a month ago - Sanofi

Sanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities

/PRNewswire/ -- Sanofi has announced the winners of its 2023 Health Equity Accelerator Awards, honoring 10 nonprofit organizations that exemplify the company's...

News Image
a month ago - FinancialNewsMedia

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

News Image
a month ago - NetworkNewsWire

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

/PRNewswire/ -- GLP-1 agonists have become incredibly popular obesity drugs, reshaping the standard of care as people increasingly turn to the new class of...

News Image
a month ago - The Motley Fool

Sanofi (SNY) Q3 2023 Earnings Call Transcript

SNY earnings call for the period ending September 30, 2023.

News Image
a month ago - Seeking Alpha

Sanofi shares hit 52-week low amid downwardly revised forecast (SNY)

Sanofi (SNY) shares hit a new 52-week low amid a downwardly revised forecast and news that it intends to spin out its consumer products division. Read more here.

News Image
a month ago - Investor's Business Daily

Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review

Microsoft, Google, Amazon and Meta led big earnings.

News Image
a month ago - InvestorPlace

Why Are Stocks Up Today?

Stocks are up on Friday as investors react to a positive earnings report from Amazon that has other tech stocks moving in sympathy with AMZN.

News Image
a month ago - InvestorPlace

Why Is Nikola (NKLA) Stock Up 4% Today?

Nikola stock is on the rise Friday as shares of NKLA continue a climb this week on positive news of $165 million award from a court case.

News Image
a month ago - InvestorPlace

SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff

The happy talk in Sanofi's press release didn't help with analysts, who have been disappointed in the company and SNY stock all year.

News Image
a month ago - Investor's Business Daily

Sanofi Crashes 16% As Third Quarter Comes In Light Ahead Of Spinoff

The company announced plans to spin off its consumer health division.

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday!